Safety and Efficacy of Laparoscopic Radiofrequency Ablation for Hepatic Hemangiomas: A Multicenter Retrospective Study

Wen, Shunqian; Wu, Ming; Len, Kai-Ming; Hu, Qiu-Hui; Xie, Xueyi; Wu, Qing; Liao, Guanqun

doi:10.5604/01.3001.0010.8653

Cited by 16 publications

(14 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the treatment is not considered as curative because recurrence is common due to vascular recanalization [14,15]. Recently, energy-based techniques, such as RFA and MWA, which were historically used to treat hepatocellular carcinoma, have been used in treating hepatic hemangiomas [17][18][19][20][21][22][23][24][25][26]. Our previous studies also have demonstrated the efficacy and safety of MWA as a new therapeutic modality for large hepatic hemangiomas [26,30,31].…”

Section: Discussionmentioning

confidence: 99%

“…Although effective, SR is associated with large trauma, substantial recovery time and morbidity [4,6]. With the development of minimally invasive procedures, transcatheter arterial embolization (TAE) [7][8][9][10][11][12][13][14][15][16], radiofrequency ablation (RFA) [17][18][19][20][21][22][23] and microwave ablation (MWA) [24][25][26] have been used to treat hepatic hemangiomas. They have been proven effective and less invasive than surgery.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Microwave ablation versus transcatheter arterial embolization for large hepatic hemangiomas: clinical outcomes

Shi

Shen

Ding

et al. 2020

International Journal of Hyperthermia

View full text Add to dashboard Cite

Purpose: To evaluate the safety and effect of microwave ablation (MWA) compared with transcatheter arterial embolization (TAE) for the treatment of large hepatic hemangiomas. Materials and methods: A total of 135 patients with symptomatic or/and enlarging hepatic hemangiomas (5-10 cm) from two centers underwent either MWA (n ¼ 82) or TAE (n ¼ 53) as first-line treatment. We compared the two groups in terms of radiologic response, clinical response, operative time, postoperative analgesic requirements, hospital stay and complications. Results: MWA had a significantly higher rate of complete radiologic response (89.0% vs. 37.7%, p<.001) and complete clinical response (88.6% vs. 69.2%, p¼.046), fewer minor complications (43.9% vs. 66.0%, p¼.019), shorter time of using analgesics (p<.001) and shorter hospital stays (p¼.003) than did TAE. The operative time and major complications were comparable between the two groups. Conclusion: Both MWA and TAE are safe and effective in treating patients with large hepatic hemangiomas. MWA had a higher rate of complete response than did TAE, and it was associated with fewer minor complications, faster recovery and shorter hospital stay.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Microwave ablation versus transcatheter arterial embolization for large hepatic hemangiomas: clinical outcomes

Shi

Shen

Ding

et al. 2020

International Journal of Hyperthermia

View full text Add to dashboard Cite

show abstract

“…Radiofrequency ablation (RFA) is one new developed and minimally invasive cancer therapy technique. Studies showed that it was widely used to treat various tumors, such as liver tumors, renal tumors [5,6]. The efficacy and safety of RFA for lung cancers are also evaluated and studies suggested that RFA was one safe and efficient treatment for the patients with lung cancers [7].…”

Section: Introductionmentioning

confidence: 99%

The value of Cone-Beam CT-guided radiofrequency ablation in the treatment of pulmonary malignancies (≤3 cm)

Xiang

Wang

et al. 2019

Bioscience Reports

View full text Add to dashboard Cite

The aim of this study is to explore the safety and efficacy of Cone-Beam computed tomography (CBCT) guided radiofrequency ablation (RFA) in the treatment of pulmonary malignancies. Thirty-one patients with pulmonary malignant tumors (≤3 cm in diameter) were enrolled to this study. Total 43 CBCT guided RFA treatments were performed, including 7 patients undergoing multiple treatments. The target tumor puncture success rate, tumor remission rate, postoperative cumulative survival rate, tumor-free survival rate and complication rate were analyzed. All 43 CBCT guided RFA procedures successfully punctured the target tumors. Complications included five cases of pneumothorax and three cases of hemoptysis. For the 31 patients who underwent CBCT guided RFA, the 1- and 2-year cumulative survival rates were 80.6 and 54.8%, respectively. The 1- and 2-year disease-free survival rates were 54.8 and 32.3%, respectively. The 1-, 3- and 6-month remission rates were 78.4, 68.7 and 63.3%, respectively. The average cumulative radiation dose and average effective radiation dose were 194.62 ± 105.51 mGy and 5.41 ± 3.45 mSv, respectively. CBCT help to shorten the operation time, reduce the unnecessary interventions and also reduce the incidence of complications. CBCT guided RFA is one safe and efficacious treatment for pulmonary malignancies.

show abstract

“…Radiofrequency ablation (RFA) is a minimally invasive and effective treatment option for patients with hepatic hemangioma. In this treatment, the main arterial blood supply area of the hemangioma is destroyed to limit the hemangioma as much as possible and reduce the size of the residual lesion (26,27). Several reports have shown a satisfactory effect of RFA treatment on hepatic hemangioma; the tumor volume appears to shrink, and the patient symptoms are relieved (26,28).…”

Section: Discussionmentioning

confidence: 99%

“…In this treatment, the main arterial blood supply area of the hemangioma is destroyed to limit the hemangioma as much as possible and reduce the size of the residual lesion (26,27). Several reports have shown a satisfactory effect of RFA treatment on hepatic hemangioma; the tumor volume appears to shrink, and the patient symptoms are relieved (26,28). Some reports have described the application of MIA in the treatment of hepatic hemangioma in some centers; the treatment principle is similar to that of RFA.…”

Section: Discussionmentioning

confidence: 99%

Real-world data on the clinicopathological traits and outcomes of hospitalized liver hemangioma patients: a multicenter study

Tang¹,

Wang²,

Mao³

et al. 2021

Ann Transl Med

View full text Add to dashboard Cite

Background: There is currently a lack of consensus regarding the clinical features, diagnosis, treatment indications and options, and risk assessment of hepatic hemangioma patients.Methods: This was a multicenter, real-world study that analyzed a large number of hepatic hemangioma cases in China and included patient data on epidemiology, diagnosis, treatment methods, and outcomes.Results: A total of 5,143 patients hospitalized for hepatic hemangioma were included, of whom 34.42% were male and 65.58% were female. The age distribution was concentrated between 30 and 60 years old, accounting for 87.41% of the patients. Among the hepatic hemangioma patients, 60.8% had only one tumor, with the most common pathological type being cavernous hemangioma (96.07% of cases). The treatment motivations and indications included anxiety, obvious clinical symptoms, rapid tumor growth, unclear diagnoses and acute emergencies. Overall, 41.4% of the patients were treated for psychological reasons, while 30.59% were treated because they presented obvious (primarily nonspecific) clinical symptoms.Hepatic resection was the main therapeutic method and was based on various indications. There were a small number of patients with Kasabach-Merritt syndrome, according to its generally recognized definition.Conclusions: Most patients in this study who were hospitalized for hepatic hemangioma did not meet the indications for requiring treatment. Surveillance is the recommended course of action for definitively diagnosed hepatic hemangioma, and a new classification system is needed to standardize the diagnosis of this condition.

show abstract

Safety and Efficacy of Laparoscopic Radiofrequency Ablation for Hepatic Hemangiomas: A Multicenter Retrospective Study

Cited by 16 publications

References 19 publications

Microwave ablation versus transcatheter arterial embolization for large hepatic hemangiomas: clinical outcomes

Microwave ablation versus transcatheter arterial embolization for large hepatic hemangiomas: clinical outcomes

The value of Cone-Beam CT-guided radiofrequency ablation in the treatment of pulmonary malignancies (≤3 cm)

Real-world data on the clinicopathological traits and outcomes of hospitalized liver hemangioma patients: a multicenter study

Contact Info

Product

Resources

About